Navigation Links
Mithridion Announces Progress With Drugs for Alzheimer's Disease and Schizophrenia
Date:11/12/2009

MADISON, Wis., Nov 12 /PRNewswire/ -- Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia. New product options have been developed for MCD-386, a clinical-stage drug candidate with "first-in-class" potential for improving memory and cognition in AD, improving cognition in schizophrenia, and for disease-modifying effects (or stopping disease progression) in AD. The new product options, all in preclinical research, include MCD-386 Forte (a high dose version), MCD-386 Transderm (potentially deliverable via a skin patch), and MCD-396 Forte/Transderm, combining the benefits of both technologies.

Mithridion also announced progress in laboratory studies demonstrating the potential disease-modifying activity of its drug leads, or their ability to stop or slow down the disease processes in AD. No currently available drug treats the underlying causes of AD, and this is a major unmet clinical need.

Trevor M Twose, CEO, will present these results in a corporate overview on Thursday November 12, 2009, at 12:05 p.m. at the 7th Annual MidAmerica Healthcare Venture Forum taking place on November 11-12, 2009, at the Monona Terrace conference center in Madison, WI. Mithridion is seeking major pharmaceutical company partners to develop its expanded product options. Dr. Twose will be available for one-on-one meetings.

Mithridion is currently developing a controlled release formulation of MCD-386 (MCD-386CR) for Alzheimer's disease. The first part of Phase I clinical trials was completed in late 2008, as previously announced. The company plans to evaluate the safety, tolerability and pharmacokinetics of MCD-386CR in a randomized, double-blind, placebo-controlled, ascending multiple-dose Phase Ib study to commence in the fourth qu
'/>"/>

SOURCE Mithridion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
2. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
3. Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
4. Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting
5. Pulmo BioTech Inc. Announces that Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Shows Early Indications of Being Able to Diagnose a Wide Range of Medical Conditions Affecting the Physical and/or Biological Integrity of the Pulmon
6. EyeScience(TM) Announces New Program to Improve Patient Compliance and Practice Profits
7. Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps
8. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
9. Natural Alternatives International, Inc. Announces Filing of Patent Infringement Lawsuit
10. Nutri-Force Nutrition Announces the Completion of Its New Manufacturing Facility
11. Stryker Announces Agreements To Acquire Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Mar. 27, 2015 Research and Markets ... "Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative ... report to their offering. The global intraoperative ... of 3.5% from 2014 to 2019 It ... a number of forces that favor this market. The ...
(Date:3/31/2015)... , March 31, 2015 ... 2015" therapeutic market research report of 68 pages ... online business intelligence library. The report ... on the therapeutic development for Pemphigus , ... assessment by drug target, mechanism of action (MoA), ...
(Date:3/31/2015)... 2015  Dr. Renu Razdan of leading Indian ... Drug Congress in April to discuss the latest, progressive announcement ... orphan drugs below: India,s ... of Health that if a new drug is approved and ... in India with waiver of clinical ...
Breaking Medicine Technology:Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market 2015-2019 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2
... 20, 2011 Seven Summits Research issues critical PriceWatch Alerts ... see what our analysts have discovered about these stocks read ... (Note: You may have to copy this link into ... PriceWatch Alerts cover the following stocks: Intel Corporation (Nasdaq: ...
... China Nuvo Solar Energy, Inc. (OTCQB: CNUV) ... Company,s requested corporate name change to SurgLine International, Inc. ("SI" ... of Directors to change the Company,s name. SurgLine, Inc. will ... a result of the Nevada approval, the Company will file ...
Cached Medicine Technology:Critical Alerts For Intel, Mosaic, Deckers, Foot Locker, and Jazz Pharmaceuticals Released By Seven Summits Research 2China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc. 2
(Date:3/31/2015)... (PRWEB) March 31, 2015 The American ... events. The schedule for April will include interesting workshops, ... New Student Orientation, 9-11 a.m. April 6, ACTCM welcomes ... Room D at the Pioneer Square Campus located at ... Aid, 12:30-1:30 p.m. April 14, Students will be updated ...
(Date:3/31/2015)... Many people, including the ones with ... and cycling are only for able-bodied participants. , ... Institute aims to change that thinking. , The ... an Adaptive Sports Expo on Saturday, April 11 (10 ... in Hollywood. , The event will showcase a ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 On March 26, ... Go Down the Silicone Slope?” provides a look into the ... filler , and laser treatments . The article suggests ... reality TV stars such as Kim Kardashian and Kylie Jenner ... media are increasingly seen as significant influences on the self-esteem ...
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 Dr. Russell ... for Advanced Reconstruction. He was recently quoted in an ... caused by lymphatic issues, causing fluid retention and tissue swelling. ... procedure to relieve and / or improve lymphedema symptoms. ... improve or alleviate the symptoms of lymphedema. The goal ...
(Date:3/31/2015)... March 31, 2015 Beckman Coulter is sponsoring ... USP 787: “Subvisible Particulate Matter in Therapeutic Protein Injections”,” an ... new demands in counting particles in liquids, with a focus ... webinar is free to attend and will be broadcast live ... posted a new test for protein-based materials, known as ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces April Event Schedule 2Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3
... ban on junk food in school canteens following a report ... its report// has shown concern about the increasing number of ... out by DDRC in 38 schools showed that one in ... food rampant in the school canteens contributed towards this cause. ...
... the source or inspiration of most new drugs created in the ... work in the natural// products branch of the National Cancer ... all new drugs approved from January 1981 through June 2006 for ... wide range of conditions. ,Only thirty percent of the ...
... the high during weekends. This is attributed to the quality ... patients. This study was conducted by William J. Kostis and ... New Jersey in New Brunswick. ,Kostis ... between the years 1987 and 2002. These were patients suffering ...
... Former Chhattisgarh's chief minister Ajit Jogi was hospitalized here ... arrested in connection// with the murder of Nationalist Congress ... was brought to Raipur at 4.10 a.m. Monday and ... chest pain," Jogi's family sources told IANS. ...
... A new study that was published in Britain indicates that the ... still more than the desired// level. Health experts opine that cardiac ... salt intake. ,According to the report, there is a ... last measured in 2001. Men have cut down their salt intake ...
... hormone that is important in the control of blood pressure ... way to prevent or treat the deadly cancer, according to ... scientists said that in mice treated with the hormone, angiotensin-(1-7), ... not receive the treatment, the tumor size more than doubled. ...
Cached Medicine News:Health News:Drug for Blood Pressure also Treats Lung Cancer 2
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Intermittent catheter - Ready-to-Use Sterile, Enclosed System...
... The VerifyNow (Ultegra) System is ... which measures platelet induced aggregation as ... system consists of an instrument, a ... assay device contains reagents based on ...
... The Model 700 Whole Blood/Optical Lumi-Aggregometer available ... This new Aggregometer measures platelet function on ... blood or optical density in plasma with ... method. The Model 700 Aggregometer also has ...
Medicine Products: